Renal replacement therapy as a treatment for severe refractory hypercalcemia

Minerva Endocrinol. 2014 Sep;39(3):231-3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenoma / complications
  • Adenoma / surgery
  • Adult
  • Carcinoma / complications
  • Carcinoma / surgery
  • Cinacalcet
  • Diphosphonates / therapeutic use
  • Drug Resistance
  • Emergencies
  • Female
  • Furosemide / therapeutic use
  • Hemodiafiltration
  • Hemofiltration*
  • Humans
  • Hydroxycholecalciferols / therapeutic use
  • Hypercalcemia / drug therapy
  • Hypercalcemia / etiology
  • Hypercalcemia / therapy*
  • Hypoparathyroidism / etiology
  • Leukemia-Lymphoma, Adult T-Cell / blood
  • Leukemia-Lymphoma, Adult T-Cell / complications
  • Male
  • Middle Aged
  • Naphthalenes / therapeutic use
  • Pamidronate
  • Pancreatitis, Acute Necrotizing / complications
  • Parathyroid Neoplasms / complications
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy / adverse effects

Substances

  • Diphosphonates
  • Hydroxycholecalciferols
  • Naphthalenes
  • Furosemide
  • Pamidronate
  • Cinacalcet
  • alfacalcidol